The trajectory of Viagra presents a challenging picture for shareholders. While the initial release generated massive profits, the end of its intellectual property protection opened the door to cheaper alternatives, https://socialbookmarkgs.com/story21666114/viagra-and-big-pharma-a-volatile-investment